Prostatis Group’s iShares S&P 500 Value ETF IVE Stock Holding History

Prostatis Group’s Portfolio IVE Stock Details IVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30,157	Closed	-$3.92M	–	69
2019 Q4	$3.92M	Buy	+30,157	New	+$3.75M	3.55%	7

Other funds holding IVE

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Prostatis Group's IVE Position: Q1 2020 in Review

Prostatis Group sold out of iShares S&P 500 Value ETF (IVE) in Q1 2020, closing a stake of 30,157 shares — an estimated $3.92M sold.

Prostatis Group first reported a position in IVE in Q4 2019 and held it in 1 quarter. The position peaked at $3.92M in Q4 2019. 759 funds tracked by Wall St. Rank hold IVE as of Q1 2020.

Prostatis Group reported no remaining iShares S&P 500 Value ETF position as of Q1 2020 after selling out during the quarter.
Prostatis Group sold 30,157 iShares S&P 500 Value ETF shares in Q1 2020, an estimated $3.92M.
Prostatis Group first reported a position in iShares S&P 500 Value ETF in Q4 2019 and held it in 1 quarter.
Prostatis Group's iShares S&P 500 Value ETF position peaked at $3.92M in Q4 2019.
759 funds tracked by Wall St. Rank held iShares S&P 500 Value ETF as of Q1 2020.

Based on Prostatis Group's 13F filing for Q1 2020, filed 23 Mar 2023.